1. Home
  2. CORT vs FND Comparison

CORT vs FND Comparison

Compare CORT & FND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$114.53

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

N/A

Current Price

$45.91

Market Cap

4.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
FND
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
4.9B
IPO Year
2001
2014

Fundamental Metrics

Financial Performance
Metric
CORT
FND
Price
$114.53
$45.91
Analyst Decision
Buy
Hold
Analyst Count
5
23
Target Price
★ $141.00
$58.59
AVG Volume (30 Days)
815.6K
★ 2.2M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.05
EPS
0.09
★ 1.25
Revenue
$761,407,000.00
★ $4,684,088,000.00
Revenue This Year
$50.53
$3.63
Revenue Next Year
$48.75
$5.17
P/E Ratio
$1,275.83
★ $38.03
Revenue Growth
★ 12.79
5.12
52 Week Low
$28.66
$42.64
52 Week High
$126.38
$77.46

Technical Indicators

Market Signals
Indicator
CORT
FND
Relative Strength Index (RSI) 51.85 35.86
Support Level $108.33 $42.64
Resistance Level $124.30 $53.19
Average True Range (ATR) 5.17 1.66
MACD -0.14 0.12
Stochastic Oscillator 53.19 1.75

Price Performance

Historical Comparison
CORT
FND

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site. The company segments include retail segment and others.

Share on Social Networks: